Actively Recruiting

Age: 18Years +
All Genders
NCT06341166

Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse

Led by Centro Cardiologico Monzino · Updated on 2026-02-03

300

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

Sponsors

C

Centro Cardiologico Monzino

Lead Sponsor

H

Humanitas Hospital, Italy

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.

CONDITIONS

Official Title

Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Echocardiographic diagnosis of mitral valve prolapse with systolic displacement of one or both mitral leaflets of 2 mm or more above the mitral valve annulus in long-axis views
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Presence of other cardiomyopathies or moderate or worse valve diseases
  • Poor echocardiographic image quality
  • Usual contraindications for cardiac magnetic resonance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centro Cardiologico Monzino

Milan, Milan, Italy, 20131

Actively Recruiting

Loading map...

Research Team

G

Gianluca Pontone, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here